Efficacy and safety of linaclotide in patients with irritable bowel syndrome with constipation: Chinese sub‐cohort analysis of a phase III, randomized, double‐blind, placebo‐controlled trial

OBJECTIVE: To conduct a sub‐cohort analysis to evaluate the efficacy and safety of linaclotide in Chinese patients with constipation‐predominant irritable bowel syndrome (IBS‐C) using data from a completed trial (NCT01880424). METHODS: In this phase III, double‐blind, placebo‐controlled trial, IBS‐C...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Li Hua, Fang, Jing Yuan, Dai, Ning, Shen, Xi Zhong, Yang, You Lin, Sun, Jing, Yang, Yun Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314117/
https://www.ncbi.nlm.nih.gov/pubmed/35019221
http://dx.doi.org/10.1111/1751-2980.13081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314117/
https://www.ncbi.nlm.nih.gov/pubmed/35019221
http://dx.doi.org/10.1111/1751-2980.13081

Ejemplares similares